申请人:Incyte Corporation
公开号:US09290514B2
公开(公告)日:2016-03-22
The present invention relates to tricyclic heterocycles of Formula (I), which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
本发明涉及公式(I)的三环杂环化合物,它们是BET蛋白(如BRD2、BRD3、BRD4和BRD-t)的抑制剂,并可用于治疗癌症等疾病。